Home / Cabergoline / Norway
NO ATC G02CB03 · updated 2 Nov 2026
Cabergoline shortage in Norway
Is there a Cabergoline shortage in Norway?
Yes. As of 2 Nov 2026, 1 Cabergoline product is reported short in Norway. The company estimate for the return is 17 Jan 2027. Main reason: increased demand.
Also short in Canada, Italy, Czechia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Dostinex 0,5 mg tablett, 8 stk boks av plast anticipated | Pfizer AS | 16 Nov 2026 | 17 Jan 2027 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).